Cargando…

The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor

The pan-PI3K inhibitors are one treatment option for triple-negative breast cancer (TNBC). However, this treatment is ineffective for unknown reasons. Here, we report that aberrant expression of wingless-type MMTV integration site family (WNT) and activated WNT signals, which crosstalk with the PI3K...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzeng, Huey-En, Yang, Lixin, Chen, Kemin, Wang, Yafan, Liu, Yun-Ru, Pan, Shiow-Lin, Gaur, Shikha, Hu, Shuya, Yen, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484439/ https://www.ncbi.nlm.nih.gov/pubmed/25857298

Ejemplares similares

GDC-0941 activates integrin linked kinase (ILK) expression to cause resistance to GDC-0941 in breast cancer by the tumor necrosis factor (TNF)-α signaling pathway
por: Chen, Haifeng, et al.
Publicado: (2022)

Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling
por: Usman, Muhammad Waqas, et al.
Publicado: (2018)

The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy
por: Ehrhardt, Michael, et al.
Publicado: (2014)

The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma
por: Amirouchene-Angelozzi, Nabil, et al.
Publicado: (2016)

Author Correction: Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling
por: Usman, Muhammad Waqas, et al.
Publicado: (2019)

The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer
por: Wang, Lingfei, et al.
Publicado: (2017)

Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
por: Mehraj, Umar, et al.
Publicado: (2022)

The FDA approved PI3K inhibitor GDC‐0941 enhances in vitro the anti‐neoplastic efficacy of Axitinib against c‐myc‐amplified high‐risk medulloblastoma
por: Ehrhardt, Michael, et al.
Publicado: (2018)

Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics
por: Lu, Tong, et al.
Publicado: (2017)

A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer
por: Schöffski, Patrick, et al.
Publicado: (2018)

The MEK-ERK-MST1 Axis Potentiates the Activation of the Extrinsic Apoptotic Pathway during GDC-0941 Treatment in Jurkat T Cells
por: Nováková, Jana, et al.
Publicado: (2019)

(11)C-Labeled Pictilisib (GDC-0941) as a Molecular Tracer Targeting Phosphatidylinositol 3-Kinase (PI3K) for Breast Cancer Imaging
por: Han, Na, et al.
Publicado: (2019)

Canonical Wnt Pathway Inhibitor ICG-001 Induces Cytotoxicity of Multiple Myeloma Cells in Wnt-Independent Manner
por: Grigson, Eileen R., et al.
Publicado: (2015)

Factors affecting the role of canonical Wnt inhibitor Dickkopf-1 in cancer progression
por: Doucet, Dakota, et al.
Publicado: (2023)

Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling
por: Sheng, Ren, et al.
Publicado: (2014)

Sclerostin small-molecule inhibitors promote osteogenesis by activating canonical Wnt and BMP pathways
por: Sangadala, Sreedhara, et al.
Publicado: (2023)

Wnt Signaling Upregulates Teneurin-3 Expression via Canonical and Non-canonical Wnt Pathway Crosstalk
por: Bastías-Candia, Sussy, et al.
Publicado: (2019)

Surrogate Wnt agonists that phenocopy canonical Wnt/β-catenin signaling
por: Janda, Claudia Y., et al.
Publicado: (2017)

THE CANONICAL WNT PATHWAY IN GASTRIC CARCINOMA
por: de OLIVEIRA, Levindo Alves, et al.
Publicado: (2019)

The structural biology of canonical Wnt signalling
por: Agostino, Mark, et al.
Publicado: (2020)

Wnt Glycation Inhibits Canonical Signaling
por: Ye, Zhennan, et al.
Publicado: (2019)

Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis
por: Døsen, Guri, et al.
Publicado: (2006)

WNT16 antagonises excessive canonical WNT activation and protects cartilage in osteoarthritis
por: Nalesso, Giovanna, et al.
Publicado: (2017)

Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting Mitophagy
por: Liu, Li-Juan, et al.
Publicado: (2022)

Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics
por: Kikuchi, Hugh, et al.
Publicado: (2023)

Beyond TNBC: Repositioning of Clofazimine Against a Broad Range of Wnt-Dependent Cancers
por: Xu, Jiabin, et al.
Publicado: (2020)

Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
por: Yuzugullu, Haluk, et al.
Publicado: (2009)

Role of Wnt canonical pathway in hematological malignancies
por: GE, Xueling, et al.
Publicado: (2010)

Probing the canonicity of the Wnt/Wingless signaling pathway
por: Franz, Alexandra, et al.
Publicado: (2017)

Discrete roles of canonical and non-canonical Wnt signaling in hematopoiesis and lymphopoiesis
por: Famili, F, et al.
Publicado: (2015)

mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer
por: Mashima, Tetsuo, et al.
Publicado: (2017)

Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors
por: Fu, Wen-bin, et al.
Publicado: (2018)

Agonistic and Antagonistic Roles for TNIK and MINK in Non-Canonical and Canonical Wnt Signalling
por: Mikryukov, Alexander, et al.
Publicado: (2012)

Components of the Canonical and Non-Canonical Wnt Pathways Are Not Mis-Expressed in Pituitary Tumors
por: Colli, Leandro Machado, et al.
Publicado: (2013)

Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases
por: Ackers, Ian, et al.
Publicado: (2017)

A Switch from Canonical to Noncanonical Wnt Signaling Mediates Drug Resistance in Colon Cancer Cells
por: Bordonaro, Michael, et al.
Publicado: (2011)

Alteration of Wnt5a expression and of the non-canonical Wnt/PCP and Wnt/PKC-Ca(2+) pathways in human osteoarthritis osteoblasts
por: Martineau, Xavier, et al.
Publicado: (2017)

Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma
por: Pasca di Magliano, Marina, et al.
Publicado: (2007)

Induction of otic structures by canonical Wnt signalling in medaka
por: Bajoghli, Baubak, et al.
Publicado: (2009)

Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin
por: Albers, Joachim, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c2ouidtfr0tfcuh6na3vpn298n